UiPath (NYSE:PATH) Price Target Increased to $15.00 by Analysts at Wells Fargo & Company

UiPath (NYSE:PATH) had its price objective upped by Wells Fargo & Company from $14.00 to $15.00 in a research note issued on Friday, Benzinga reports. The firm currently has an “equal weight” rating on the healthcare company’s stock. Wells Fargo & Company‘s price target would indicate a potential upside of 17.74% from the stock’s current price.

A number of other equities analysts also recently commented on the stock. DA Davidson cut their target price on shares of UiPath from $24.00 to $13.00 and set a “neutral” rating on the stock in a research note on Thursday, May 30th. JPMorgan Chase & Co. decreased their target price on UiPath from $28.00 to $19.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Bank of America raised their target price on UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a report on Friday. Scotiabank decreased their target price on shares of UiPath from $30.00 to $25.00 and set a “sector perform” rating for the company in a research note on Wednesday, May 29th. Finally, Morgan Stanley dropped their price target on shares of UiPath from $25.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 30th. Sixteen equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $18.35.

UiPath Stock Up 0.2 %

PATH stock opened at $12.74 on Friday. The company has a market cap of $7.30 billion, a price-to-earnings ratio of -79.63 and a beta of 0.87. The business has a fifty day simple moving average of $12.22 and a 200-day simple moving average of $16.80. UiPath has a 52 week low of $10.37 and a 52 week high of $27.87.

UiPath (NYSE:PATH) last announced its quarterly earnings results on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.03 by $0.01. The company had revenue of $316.00 million during the quarter, compared to analyst estimates of $303.69 million. UiPath had a negative return on equity of 2.97% and a negative net margin of 6.41%. The firm’s revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.09) earnings per share. As a group, analysts expect that UiPath will post -0.22 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Sanctuary Advisors LLC bought a new position in shares of UiPath in the 2nd quarter worth about $155,000. Advisory Alpha LLC acquired a new stake in UiPath during the second quarter worth about $131,000. Capital Impact Advisors LLC lifted its holdings in UiPath by 162.9% in the second quarter. Capital Impact Advisors LLC now owns 36,400 shares of the healthcare company’s stock worth $462,000 after acquiring an additional 22,553 shares during the last quarter. Sunbelt Securities Inc. boosted its stake in UiPath by 15.4% in the second quarter. Sunbelt Securities Inc. now owns 20,970 shares of the healthcare company’s stock valued at $266,000 after acquiring an additional 2,792 shares during the period. Finally, Northwestern Mutual Wealth Management Co. boosted its stake in UiPath by 2,495.4% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 682,078 shares of the healthcare company’s stock valued at $8,649,000 after acquiring an additional 655,798 shares during the period. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.